The same authors reported the construction of a recombinant trispecific single-chain Fv derivative directed against CD123, CD33 and CD16, mediated effective elimination of AML cells, including leukemic stem cells [69]. The gene discussed is IL3RA; the disease is acute myeloid leukemia.